{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:22:25Z","timestamp":1787728945647,"version":"build-2784847793"},"reference-count":69,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.cgh.2021.08.050","type":"journal-article","created":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T11:43:19Z","timestamp":1630582999000},"page":"216-226.e42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["A Cost-Effectiveness Analysis for Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Prophylaxis in the United States"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0944-9934","authenticated-orcid":false,"given":"Nikhil R.","family":"Thiruvengadam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Saumoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yecheskel","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Attala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Triggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Kochman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2021.08.050_bib1","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1056\/NEJM199609263351301","article-title":"Complications of endoscopic biliary sphincterotomy","volume":"335","author":"Freeman","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2021.08.050_bib2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.gie.2016.06.051","article-title":"Adverse events associated with ERCP","volume":"85","author":"Chandrasekhara","year":"2017","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cgh.2021.08.050_bib3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/a-1075-4080","article-title":"ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) guideline","volume":"52","author":"Dumonceau","year":"2020","journal-title":"Endoscopy"},{"key":"10.1016\/j.cgh.2021.08.050_bib4","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1055\/s-2003-42614","article-title":"Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis","volume":"35","author":"Masci","year":"2003","journal-title":"Endoscopy"},{"key":"10.1016\/j.cgh.2021.08.050_bib5","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1572-0241.2001.03594.x","article-title":"Complications of diagnostic and therapeutic ERCP: a prospective multicenter study","volume":"96","author":"Masci","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.08.050_bib6","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.cgh.2011.06.033","article-title":"Endoscopic pancreatic duct stents reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients","volume":"9","author":"Sofuni","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.08.050_bib7","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s00535-010-0268-7","article-title":"Can pancreatic duct stenting prevent post-ERCP pancreatitis in patients who undergo pancreatic duct guidewire placement for achieving selective biliary cannulation? A prospective randomized controlled trial","volume":"45","author":"Ito","year":"2010","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.cgh.2021.08.050_bib8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0016-5107(03)02530-6","article-title":"Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success","volume":"59","author":"Freeman","year":"2004","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cgh.2021.08.050_bib9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1055\/s-0030-1256305","article-title":"Prophylactic 5-Fr pancreatic duct stents are superior to 3-Fr stents: a randomized controlled trial","volume":"43","author":"Zolotarevsky","year":"2011","journal-title":"Endoscopy"},{"key":"10.1016\/j.cgh.2021.08.050_bib10","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.gie.2009.10.055","article-title":"Prophylaxis of post-ERCP pancreatitis: a practice survey","volume":"71","author":"Dumonceau","year":"2010","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cgh.2021.08.050_bib11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11894-020-00796-w","article-title":"Emerging therapies to prevent post-ERCP pancreatitis","volume":"22","author":"Thiruvengadam","year":"2020","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.cgh.2021.08.050_bib12","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.pan.2017.07.008","article-title":"Rectal nonsteroidal anti-inflammatory drugs administration is effective for the prevention of post-ERCP pancreatitis: an updated meta-analysis of randomized controlled trials","volume":"17","author":"Yang","year":"2017","journal-title":"Pancreatology"},{"key":"10.1016\/j.cgh.2021.08.050_bib13","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1056\/NEJMoa1111103","article-title":"A\u00a0randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis","volume":"366","author":"Elmunzer","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2021.08.050_bib14","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1053\/j.gastro.2016.04.048","article-title":"Rectal indomethacin reduces pancreatitis in high- and low-risk patients undergoing endoscopic retrograde cholangiopancreatography","volume":"151","author":"Thiruvengadam","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.08.050_bib15","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/S0140-6736(16)30310-5","article-title":"Routine pre-procedural rectal indomethacin versus selective post-procedural rectal indomethacin to prevent pancreatitis in patients undergoing endoscopic retrograde cholangiopancreatography: a multicentre, single-blinded, randomised controlled trial","volume":"387","author":"Luo","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2021.08.050_bib16","doi-asserted-by":"crossref","first-page":"E29","DOI":"10.1055\/a-1005-6366","article-title":"Comparative effectiveness of pharmacologic and endoscopic interventions for prevention of post-ERCP pancreatitis: a network meta-analysis","volume":"8","author":"Njei","year":"2020","journal-title":"Endosc Int Open"},{"key":"10.1016\/j.cgh.2021.08.050_bib17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cgh.2013.07.026","article-title":"Aggressive hydration with lactated Ringer's solution reduces pancreatitis after endoscopic retrograde cholangiopancreatography","volume":"12","author":"Buxbaum","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.08.050_bib18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cgh.2016.06.007","article-title":"Vigorous periprocedural hydration with lactated Ringer's solution reduces the risk of pancreatitis after retrograde cholangiopancreatography in hospitalized patients","volume":"15","author":"Choi","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.08.050_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075645","article-title":"Glyceryl trinitrate for prevention of post-ERCP pancreatitis and improve the rate of cannulation: a meta-analysis of prospective, randomized, controlled trials","volume":"8","author":"Ding","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2021.08.050_bib20","doi-asserted-by":"crossref","first-page":"934","DOI":"10.14309\/ajg.0000000000000623","article-title":"Real-world practice patterns in the era of rectal indomethacin for prophylaxis against post-ERCP pancreatitis in a high-risk cohort","volume":"115","author":"Smith","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.08.050_bib21","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.gie.2019.11.013","article-title":"Practice patterns of post-ERCP pancreatitis prophylaxis techniques in the United States: a survey of advanced endoscopists","volume":"91","author":"Avila","year":"2020","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cgh.2021.08.050_bib22","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.gie.2006.07.031","article-title":"Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis","volume":"65","author":"Das","year":"2007","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cgh.2021.08.050_bib23","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/ajg.2012.442","article-title":"Does rectal indomethacin eliminate the need for prophylactic pancreatic stent placement in patients undergoing high-risk ERCP? Post hoc efficacy and cost-benefit analyses using prospective clinical trial data","volume":"108","author":"Elmunzer","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.08.050_bib24","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jamainternmed.2020.0099","article-title":"The skyrocketing cost of rectal indomethacin","volume":"180","author":"Elmunzer","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cgh.2021.08.050_bib25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13017-017-0128-3","article-title":"Acute care surgery: a means for providing cost-effective, quality care for gallstone pancreatitis","volume":"12","author":"Murphy","year":"2017","journal-title":"World J Emerg Surg"},{"key":"10.1016\/j.cgh.2021.08.050_bib26","series-title":"Quality of life measurement of patients receiving treatments for gallstone disease: options, issues and results","author":"Cook","year":"1993"},{"key":"10.1016\/j.cgh.2021.08.050_bib29","unstructured":"Acute Inpatient PPS. Available at: https:\/\/www.cms.gov\/Medicare\/Medicare-Fee-for-Service-Payment\/AcuteInpatientPPS. Accessed: February 14,\u00a02021."},{"key":"10.1016\/j.cgh.2021.08.050_bib30","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1053\/j.gastro.2007.03.065","article-title":"AGA Institute technical review on acute pancreatitis","volume":"132","author":"Forsmark","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.08.050_bib31","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1038\/ajg.2010.136","article-title":"Risk factors for post-ERCP pancreatitis in high- and low-volume centers and among expert and non-expert operators: a prospective multicenter study","volume":"105","author":"Testoni","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.08.050_bib32","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000347","article-title":"Burden of ionizing radiation in the diagnosis and management of necrotizing pancreatitis","volume":"12","author":"Thiruvengadam","year":"2021","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.cgh.2021.08.050_bib33","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/MPA.0000000000001838","article-title":"The Pancreatitis Activity Scoring System predicts clinical outcomes in patients with infected pancreatic necrosis","volume":"50","author":"Thiruvengadam","year":"2021","journal-title":"Pancreas"},{"key":"10.1016\/j.cgh.2021.08.050_bib34","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2471\/BLT.14.138206","article-title":"Thresholds for the cost-effectiveness of interventions: alternative approaches","volume":"93","author":"Marseille","year":"2015","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.cgh.2021.08.050_bib35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.gie.2014.06.045","article-title":"Incidence, severity, and mortality of post-ERCP pancreatitis: a systematic review by using randomized, controlled trials","volume":"81","author":"Kochar","year":"2015","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cgh.2021.08.050_bib36","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3748\/wjg.15.366","article-title":"Prophylactic effect of glyceryl trinitrate on post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized placebo-controlled trial","volume":"15","author":"Hao","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.08.050_bib37","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.cgh.2012.12.043","article-title":"Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a network meta-analysis","volume":"11","author":"Akbar","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.08.050_bib38","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13063-016-1251-2","article-title":"Rectal indomethacin alone versus indomethacin and prophylactic pancreatic stent\u00a0placement for preventing pancreatitis after ERCP: study protocol for a randomized controlled trial","volume":"17","author":"Elmunzer","year":"2016","journal-title":"Trials"},{"key":"10.1016\/j.cgh.2021.08.050_bib39","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/jhbp.259","article-title":"Japanese guidelines for the management of acute pancreatitis: Japanese Guidelines 2015","volume":"22","author":"Yokoe","year":"2015","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.cgh.2021.08.050_bib40","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.cgh.2007.07.008","article-title":"Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent","volume":"5","author":"Sofuni","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.08.050_bib41","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.pan.2017.07.008","article-title":"Rectal nonsteroidal anti-inflammatory drugs administration is effective for the prevention of post-ERCP pancreatitis: an updated meta-analysis of randomized controlled trials","volume":"17","author":"Yang","year":"2017","journal-title":"Pancreatology"},{"key":"10.1016\/j.cgh.2021.08.050_bib42","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/apt.12488","article-title":"Meta-analysis: rectal indomethacin for the prevention of post-ERCP pancreatitis","volume":"38","author":"Yaghoobi","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2021.08.050_bib43","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1056\/NEJMoa1111103","article-title":"A\u00a0randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis","volume":"366","author":"Elmunzer","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2021.08.050_bib44","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/S0016-5085(03)00384-6","article-title":"Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography","volume":"124","author":"Murray","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.08.050_bib45","first-page":"330","article-title":"[Effect of the administration of rectal indomethacin on amylase serum levels after endoscopic retrograde cholangiopancreatography, and its impact on the development of secondary pancreatitis episodes]","volume":"99","author":"Montano Loza","year":"2007","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.cgh.2021.08.050_bib46","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3748\/wjg.15.366","article-title":"Prophylactic effect of glyceryl trinitrate on post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized placebo-controlled trial","volume":"15","author":"Hao","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.08.050_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075645","article-title":"Glyceryl trinitrate for prevention of post-ERCP pancreatitis and improve the rate of cannulation: a meta-analysis of prospective, randomized, controlled trials","volume":"8","author":"Ding","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2021.08.050_bib48","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1046\/j.0007-1323.2001.01842.x","article-title":"Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis","volume":"88","author":"Sudhindran","year":"2001","journal-title":"Br J Surg"},{"key":"10.1016\/j.cgh.2021.08.050_bib49","doi-asserted-by":"crossref","first-page":"E29","DOI":"10.1055\/a-1005-6366","article-title":"Comparative effectiveness of pharmacologic and endoscopic interventions for prevention of post-ERCP pancreatitis: a network meta-analysis","volume":"8","author":"Njei","year":"2020","journal-title":"Endosc Int Open"},{"key":"10.1016\/j.cgh.2021.08.050_bib50","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cgh.2013.07.026","article-title":"Aggressive hydration with lactated Ringer's solution reduces pancreatitis after endoscopic retrograde cholangiopancreatography","volume":"12","author":"Buxbaum","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.08.050_bib51","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cgh.2016.06.007","article-title":"Vigorous periprocedural hydration with lactated ringer's solution reduces the risk of pancreatitis after retrograde cholangiopancreatography in hospitalized patients","volume":"15","author":"Choi","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.08.050_bib52","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.cgh.2012.12.043","article-title":"Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a network meta-analysis","volume":"11","author":"Akbar","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.08.050_bib53","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.cgh.2007.07.008","article-title":"Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent","volume":"5","author":"Sofuni","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.08.050_bib54","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.cgh.2011.06.033","article-title":"Endoscopic pancreatic duct stents reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients","volume":"9","author":"Sofuni","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.08.050_bib55","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/S0140-6736(16)30310-5","article-title":"Routine pre-procedural rectal indomethacin versus selective post-procedural rectal indomethacin to prevent pancreatitis in patients undergoing endoscopic retrograde cholangiopancreatography: a multicentre, single-blinded, randomised controlled trial","volume":"387","author":"Luo","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2021.08.050_bib56","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1572-0241.2007.01165.x","article-title":"Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP","volume":"102","author":"Sotoudehmanesh","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.08.050_bib57","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/ajg.2014.9","article-title":"A\u00a0randomized trial of rectal indomethacin and sublingual nitrates to prevent post-ERCP pancreatitis","volume":"109","author":"Sotoudehmanesh","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.08.050_bib58","first-page":"838","article-title":"Aggressive hydration with lactated Ringer's solution as the prophylactic intervention for postendoscopic retrograde cholangiopancreatography pancreatitis: a randomized controlled double-blind clinical trial","volume":"20","author":"Shaygan-Nejad","year":"2015","journal-title":"J\u00a0Res Med Sci"},{"key":"10.1016\/j.cgh.2021.08.050_bib59","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1572-0241.2006.00380.x","article-title":"Risk factors for post-ERCP pancreatitis: a prospective multicenter study","volume":"101","author":"Cheng","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.08.050_bib60","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.gie.2014.06.045","article-title":"Incidence, severity, and mortality of post-ERCP pancreatitis: a systematic review by using randomized, controlled trials","volume":"81","author":"Kochar","year":"2015","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cgh.2021.08.050_bib61","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1055\/s-0030-1256305","article-title":"Prophylactic 5-Fr pancreatic duct stents are superior to 3-Fr stents: a randomized controlled trial","volume":"43","author":"Zolotarevsky","year":"2011","journal-title":"Endoscopy"},{"key":"10.1016\/j.cgh.2021.08.050_bib62","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0016-5107(03)02530-6","article-title":"Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success","volume":"59","author":"Freeman","year":"2004","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cgh.2021.08.050_bib63","first-page":"322","article-title":"Role of pancreatic stents in prevention of post-ERCP pancreatitis","volume":"5","author":"Freeman","year":"2004","journal-title":"JOP"},{"key":"10.1016\/j.cgh.2021.08.050_bib64","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1067\/mge.2001.117550","article-title":"Risk factors for post-ERCP pancreatitis: a prospective, multicenter study","volume":"54","author":"Freeman","year":"2001","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cgh.2021.08.050_bib65","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1038\/ajg.2010.136","article-title":"Risk factors for post-ERCP pancreatitis in high- and low-volume centers and among expert and non-expert operators: a prospective multicenter study","volume":"105","author":"Testoni","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.08.050_bib66","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1111\/j.1572-0241.2007.01279.x","article-title":"Incidence rates of post-ERCP complications: a systematic survey of prospective studies","volume":"102","author":"Andriulli","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.08.050_bib67","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1053\/j.gastro.2016.04.048","article-title":"Rectal indomethacin reduces pancreatitis in high- and low-risk patients undergoing endoscopic retrograde cholangiopancreatography","volume":"151","author":"Thiruvengadam","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.08.050_bib68","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13017-017-0128-3","article-title":"Acute care surgery: a means for providing cost-effective, quality care for gallstone pancreatitis","volume":"12","author":"Murphy","year":"2017","journal-title":"World J Emerg Surg"},{"key":"10.1016\/j.cgh.2021.08.050_bib69","series-title":"Quality of life measurement of patients receiving treatments for gallstone disease: options, issues and results","author":"Cook","year":"1993"},{"key":"10.1016\/j.cgh.2021.08.050_bib72","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.gie.2016.08.020","article-title":"Cost utility of ERCP-based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis","volume":"85","author":"Njei","year":"2017","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cgh.2021.08.050_bib74","unstructured":"Acute inpatient PPS. Available at: https:\/\/www.cms.gov\/Medicare\/Medicare-Fee-for-Service-Payment\/AcuteInpatientPPS. Accessed: February 14,\u00a02021."}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356521009307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356521009307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:36:59Z","timestamp":1761543419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356521009307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1542356521009307"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2021.08.050","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Cost-Effectiveness Analysis for Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Prophylaxis in the United States","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2021.08.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the AGA Institute","name":"copyright","label":"Copyright"}]}}